Artículos con órdenes de acceso público - Frederik A. VerburgMás información
No disponibles en ningún lugar: 2
Balancing the benefits and harms of thyroid cancer surveillance in survivors of Childhood, adolescent and young adult cancer: Recommendations from the international Late …
SC Clement, LCM Kremer, FA Verburg, JH Simmons, M Goldfarb, ...
Cancer treatment reviews 63, 28-39, 2018
Órdenes: Dutch Cancer Society
Recombinant or endogenous thyroid-stimulating hormone for radioactive iodine therapy in thyroid cancer: state of knowledge and current controversies
HI Coerts, B de Keizer, RJ Marlowe, FA Verburg
European Journal of Endocrinology 188 (2), R23-R35, 2023
Órdenes: Dutch Cancer Society
Disponibles en algún lugar: 11
The treatment of differentiated thyroid cancer in children: emphasis on surgical approach and radioactive iodine therapy
SA Rivkees, EL Mazzaferri, FA Verburg, C Reiners, M Luster, CK Breuer, ...
Endocrine reviews 32 (6), 798-826, 2011
Órdenes: US National Institutes of Health
EANM practice guideline/SNMMI procedure standard for RAIU and thyroid scintigraphy
L Giovanella, AM Avram, I Iakovou, J Kwak, SA Lawson, E Lulaj, M Luster, ...
European journal of nuclear medicine and molecular imaging 46, 2514-2525, 2019
Órdenes: US Department of Defense
Combination of peptide receptor radionuclide therapy with fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma
MC Kreissl, H Hänscheid, M Löhr, FA Verburg, M Schiller, M Lassmann, ...
Radiation Oncology 7, 1-11, 2012
Órdenes: German Research Foundation
2022 European Thyroid Association Guideline for the management of pediatric Graves’ disease
CF Mooij, TD Cheetham, FA Verburg, A Eckstein, SH Pearce, J Léger, ...
European thyroid journal 11 (1), 2022
Órdenes: UK Medical Research Council
Differentiated thyroid cancer patients potentially benefitting from postoperative I-131 therapy: a review of the literature of the past decade
FA Verburg, G Flux, L Giovanella, D van Nostrand, K Muylle, M Luster
European journal of nuclear medicine and molecular imaging 47 (1), 78-83, 2020
Órdenes: Cancer Research UK
Sonographic features differentiating follicular thyroid cancer from follicular adenoma–a meta-analysis
M Borowczyk, K Woliński, B Więckowska, E Jodłowska-Siewert, ...
Cancers 13 (5), 938, 2021
Órdenes: Narodowe Centrum Nauki
The “reset button” revisited: why high activity 131I therapy of advanced differentiated thyroid cancer after dosimetry is advantageous for patients
FA Verburg, M Luster, L Giovanella, M Lassmann, C Chiesa, N Chouin, ...
European Journal of Nuclear Medicine and Molecular Imaging 44, 915-917, 2017
Órdenes: Cancer Research UK
Normal organ dosimetry for thyroid cancer patients treated with radioiodine as part of the multi-centre multi-national Horizon 2020 MEDIRAD project
J Taprogge, A Vergara-Gil, F Leek, C Abreu, L Vávrová, ...
European Journal of Nuclear Medicine and Molecular Imaging 50 (11), 3225-3234, 2023
Órdenes: US National Institutes of Health, National Institute for Health Research, UK …
Results from an EANM survey on time estimates and personnel responsible for main tasks in molecular radiotherapy dosimetry
PM Gabiña, KS Gleisner, M Cremonesi, C Stokke, G Flux, F Cicone, ...
European Journal of Nuclear Medicine and Molecular Imaging 50 (9), 2595-2604, 2023
Órdenes: National Institute for Health Research, UK
Follicular Thyroid Adenoma and Follicular Thyroid Carcinoma—A Common or Distinct Background? Loss of Heterozygosity in Comprehensive Microarray Study
M Borowczyk, P Dobosz, E Szczepanek-Parulska, B Budny, S Dębicki, ...
Cancers 15 (3), 638, 2023
Órdenes: Narodowe Centrum Nauki
Perioperative diagnostics of patients referred for radioiodine therapy of differentiated thyroid carcinoma: Referral center experience in an iodine-insufficient country
F Eilsberger, RM Tuttle, D Librizzi, A Pfestroff, M Luster, FA Verburg
Endocrine 72, 721-726, 2021
Órdenes: US National Institutes of Health
La información de publicación y financiación se determina de forma automática mediante un programa informático